Overall (n = 135) | With 3 initial monthly injections (n = 71) | Without 3 initial monthly injections (n = 64) | |
---|---|---|---|
Success rate at 12 months,a n (%) [95% CI] | 90 (66.7) [58.0–74.5] | 49 (69.0) [56.9–79.5] | 41 (64.1) [51.1–75.7] |
BCVA, ETDRS letters | |||
Baseline | 65.1 (13.7) | 63.6 (12.3) | 66.9 (15.1) |
Month 12 | 66.9 (15.0) | 66.8 (12.1) | 66.9 (17.8) |
Change in BCVA between initial visit and 12 months | 1.7 (10.5) | 3.3 (11.0) | 0.0 (9.6) |
P value | 0.056 | 0.015 | NS |
CRT, μm | |||
Baseline | 328.0 (100.9) | 338.6 (114.6) | 316.3 (82.5) |
Month 12 | 285.3 (84.3) | 296.1 (88.0) | 272.6 (78.6) |
Change in CRT between initial visit and 12 months | −47.0 (104.1) | −45.5 (106.0) | −48.8 (102.6) |
P value | < 0.001 | < 0.001 | < 0.001 |